Retinoblastoma has contributed much to the understanding of cancer. The pro
tein product of the RB gene, pRB, is a multifaceted regulator of transcript
ion which controls the cell cycle, differentiation and apoptosis in normal
development of specific tissues. Elucidating the mechanisms in which pRB pl
ays a critical role will enable novel therapies and strategies for preventi
on, not only for retinoblastoma, but for cancer in general.